Angiogenesis in hepatocellular carcinoma: a potential target for chemoprevention and therapy
A Bishayee, AS Darvesh - Current cancer drug targets, 2012 - ingentaconnect.com
Hepatocellular carcinoma (HCC) remains one of the most lethal cancers in the world. Since
current treatment options including surgical resection and liver transplantation offer limited …
current treatment options including surgical resection and liver transplantation offer limited …
Gene therapy in liver diseases: state-of-the-art and future perspectives
K Domvri, P Zarogoulidis, K Porpodis… - Current gene …, 2012 - ingentaconnect.com
Gene therapy is a fundamentally novel therapeutic approach that involves introducing
genetic material into target cells in order to fight or prevent disease. A number of different …
genetic material into target cells in order to fight or prevent disease. A number of different …
Efficacy, safety, and potential biomarkers of thalidomide plus metronomic chemotherapy for advanced hepatocellular carcinoma
YY Shao, ZZ Lin, C Hsu, KD Lee, CH Hsiao, YS Lu… - Oncology, 2012 - karger.com
Objectives: Thalidomide has been shown to have antitumor activity in some patients with
advanced hepatocellular carcinoma (HCC). We initiated a phase II study to determine the …
advanced hepatocellular carcinoma (HCC). We initiated a phase II study to determine the …
[HTML][HTML] Thalidomide-based multidisciplinary treatment for patients with advanced hepatocellular carcinoma: a retrospective analysis
YY Chen, HH Yen, KC Chou, SS Wu - World journal of …, 2012 - ncbi.nlm.nih.gov
AIM: To evaluate the efficacy of thalidomide in combination with other therapies to treat
patients with advanced hepatocellular carcinoma (HCC). METHODS: We performed a …
patients with advanced hepatocellular carcinoma (HCC). METHODS: We performed a …
Activity of thalidomide and capecitabine in patients with advanced hepatocellular carcinoma
Background Thalidomide has shown modest activity in advanced hepatocellular carcinomas
(HCCs). Single-agent capecitabine has also been used in patients with HCC, with objective …
(HCCs). Single-agent capecitabine has also been used in patients with HCC, with objective …